サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1268781

ヒアルロン酸ダーマフィラー市場規模、シェア、動向分析レポート用途別（しわ取り、唇形成、鼻形成）、製品別、地域別、セグメント予測、2023年～2030年

Hyaluronic Acid-based Dermal Fillers Market Size, Share & Trends Analysis Report By Application (Wrinkle Removal, Lip Augmentation, Rhinoplasty), By Product; By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 120 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
ヒアルロン酸ダーマフィラー市場規模、シェア、動向分析レポート用途別（しわ取り、唇形成、鼻形成）、製品別、地域別、セグメント予測、2023年～2030年
出版日: 2023年04月10日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ヒアルロン酸ダーマフィラー市場の成長・動向：

Grand View Research, Inc.の新しいレポートによると、世界のヒアルロン酸ダーマフィラー市場規模は、2030年までに85億9,000万米ドルに達すると推定されています。

同市場は、2023年から2030年にかけてCAGR8.9%で拡大すると予測されています。低侵襲処置の需要の増加、老年人口の増加、若い肌への意識と関心の高まり、技術の進歩などが、市場を牽引する主な要因となっています。

世界の高齢人口は増加の一途をたどっています。WHOが発表した推計によると、65歳以上の世界人口は2000年の7%から2050年には16%に増加すると予想されています。このような老年人口の増加に伴い、肥満、皮膚の老化、変形性関節症の発生率が増加することが予想されています。低侵襲手術への嗜好の高まりとともに、対象人口の世界の増加は、予測期間を通じてヒアルロン酸製品の需要を大きく促進すると予想されます。

しかし、HAベースのフィラー市場はコストが高いため、市場機会を抑制しています。HAベースの皮膚充填剤は、1mlのシリンジで提供され、1シリンジあたり600～1000米ドルのコストがかかります。ほとんどの場合、最低2シリンジの投与が必要であり、治療費は1600-2000米ドルとかなり高額になります。このような高価な製品を使用することは、低中所得国の人々にとって困難なことなのです。

ヒアルロン酸ダーマフィラー市場レポートハイライト：

  • 製品別では、2022年に単相製品が最も高い市場シェアを占めました。これは、単相製品別生み出される望ましい効果や有益な効果が、消費者の間でより高い嗜好につながるためです。
  • 用途別では、2022年にシワ補正分野が市場を独占しました。これは、美容整形への支出が増加していることと、HAベースのフィラーを使用したシワ修正技術の登場別ものと考えられます。
  • 地域別では、北米が2022年の市場を独占しました。これは、同地域における有利な政府政策、整形手術の件数の増加、高齢化率の上昇に起因していると考えられます。例えば、2021年9月に発表されたカナダ統計局の人口統計別と、カナダの60歳以上の総人口は96,88,677人である.
  • アジア太平洋市場は、日本、中国、韓国のような国の急速な経済成長と医療インフラの改善により、予測期間中に最も速い成長が期待されています。
  • ヒアルロン酸ダーマフィラー市場の主なプレーヤーは以下の通りです。

目次

第1章 調査手法と範囲

  • 市場セグメンテーションと範囲
    • 製品
    • 応用
    • 地域の範囲
    • 推定・予測のタイムライン
  • 調査手法
  • 情報調達
    • 購入したデータベース
    • GVRの内部データベース
    • 二次情報
    • 1次調査
    • 1次調査の詳細
  • 情報またはデータ分析
    • データ分析モデル
  • 市場の形成と検証
  • モデル詳細
    • 商品フロー分析
    • 出来高価格分析
  • 二次情報のリスト
  • 略語のリスト
  • 目的

第2章 エグゼクティブサマリー

  • 市場の見通し
  • セグメントの見通し
    • 製品
    • 用途
    • 領域
  • 競合考察

第3章 市場変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
  • 市場セグメンテーション
  • 普及と成長の見通しマッピング
  • 臨床試験
  • ユーザー視点の分析
    • 消費者行動分析
    • 市場影響力分析
  • 市場力学
    • 市場促進要因の分析
      • 高齢者人口の増加
      • アンチエイジングソリューションと低侵襲美容治療に対する需要の高まり
      • 再生医療および組織工学におけるアプリケーションの拡大
    • 市場抑制要因分析
      • ヒアルロン酸サイクルに伴う高額な費用と副作用
      • 厳しい規制
  • ビジネス環境分析ツール
    • ポーターのファイブフォース分析
      • 買い手の交渉力：低い
      • 供給企業の交渉力：中程度
      • 競争企業間の敵対関係：高い
      • 新規参入業者の脅威：中程度
      • 代替品の脅威：低
    • SWOT分析、PESTEL別
      • 政治と法律
      • 経済的
      • 技術的
    • 臨床試験
    • 主要取引と戦略的提携の分析
      • 合弁事業
      • 合併と買収
    • 定性的分析：ヒアルロン酸ダーマフィラー市場への新型コロナウイルス感染症（COVID-19）の影響

第4章 ヒアルロン酸ダーマフィラー市場：製品分析

  • ヒアルロン酸ダーマフィラー市場、製品別市場シェア分析、2022年および2030年
  • セグメントダッシュボード
  • 製品の市場規模、予測、傾向分析、2018～2030年
    • 単相製品
    • デュプレックス製品

第5章ヒアルロン酸ダーマフィラー市場：用途分析

  • ヒアルロン酸ダーマフィラー市場：用途市場シェア分析、2022年および2030年
  • セグメントダッシュボード
  • 用途の市場規模、予測および傾向分析、2018～2030年
    • しわの矯正
      • しわ矯正市場、2018年～2030年
    • 唇の増強
      • 唇の増強市場、2018年～2030年
    • 鼻形成
      • 鼻形成市場、2018～2030年

第6章 地域別の展望

  • 地域市場シェア分析、2022年および2030年
  • 地域市場のスナップショット（市場規模、 CAGR、トップ業種、主要企業、トップ動向）
  • 市場規模、予測および傾向分析、2022年から2030年まで
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東とアフリカ

第7章 競合分析

  • 戦略的枠組み/競合の分類（主要なイノベーター、市場リーダー、新興プレーヤー）
  • ベンダー情勢
    • Strategy Mapping
    • Launch of New Products
    • Merger and Acquisition
    • Product Approvals
    • Partnerships
    • Marketing &Promotions
  • 企業の市況分析
  • 企業プロファイル
    • Allergan
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的取り組み
      • SWOT分析
    • Galderma Laboratories LP
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的取り組み
      • SWOT分析
    • Merz Pharmaceuticals
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的取り組み
      • SWOT分析
    • Genzyme Corporation
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的取り組み
      • SWOT分析
    • Anika Therapeutics Inc
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的取り組み
      • SWOT分析
    • LG Life Sciences
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的取り組み
      • SWOT分析
    • Bio plus Co
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的取り組み
      • SWOT分析
    • Sculpt Luxury Dermal Fillers Ltd
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的取り組み
      • SWOT分析
    • Bioxis Pharmaceutical
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的取り組み
    • Sinclair Pharma
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的取り組み
    • Laboratories Vivacy
      • 会社概要
      • 財務実績
      • サービスのベンチマーク
      • 戦略的取り組み
    • Bohus Biotech AB
      • 会社概要
      • 財務実績
      • 製品のベンチマーク
      • 戦略的取り組み

第8章 推奨事項

  • 重要な洞察
図表

List of Tables

  • TABLE 1 List of secondary sources
  • TABLE 2 List of abbreviation

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Data triangulation techniques
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value-chain-based sizing & forecasting
  • FIG. 6 QFD modeling for market share assessment
  • FIG. 7 Market formulation & validation
  • FIG. 8 Hyaluronic acid-based dermal fillers market summary, 2022 (USD Million)
  • FIG. 9 Hyaluronic acid-based dermal fillers market segmentation
  • FIG. 10 Penetration & growth prospect mapping
  • FIG. 11 Market trends & outlook
  • FIG. 12 Market driver relevance analysis (Current & future impact)
  • FIG. 13 Ratio of the adult population to the total population (Million)
  • FIG. 14 Market restraint relevance analysis (Current & future impact)
  • FIG. 15 Porter's five forces analysis
  • FIG. 16 Pestel analysis
  • FIG. 17 Hyaluronic acid-based dermal fillers market: Product movement analysis
  • FIG. 18 Hyaluronic acid product outlook: Key takeaways
  • FIG. 19 Single-phase product market, 2018 - 2030 (USD Million)
  • FIG. 20 Duplex product market, 2018 - 2030 (USD Million)
  • FIG. 21 Hyaluronic acid-based dermal fillers market: Application movement analysis
  • FIG. 22 Hyaluronic acid-based dermal fillers application outlook: Key takeaways
  • FIG. 23 Wrinkle removal market, 2018 - 2030 (USD Million)
  • FIG. 24 Lip augmentation market, 2018 - 2030 (USD Million)
  • FIG. 25 Rhinoplasty market, 2018 - 2030 (USD Million)
  • FIG. 26 Others market, 2018 - 2030 (USD Million)
  • FIG. 27 Regional outlook, 2018 & 2030
  • FIG. 28 Regional marketplace: Key takeaways
  • FIG. 29 Regional market snapshot
  • FIG. 30 North America hyaluronic acid-based dermal fillers market, 2018 - 2030 (USD Million)
  • FIG. 31 U.S. hyaluronic acid-based dermal fillers market, 2018 - 2030 (USD Million)
  • FIG. 32 Canada hyaluronic acid-based dermal fillers market, 2018 - 2030 (USD Million)
  • FIG. 33 Europe hyaluronic acid-based dermal fillers market, 2018 - 2030 (USD Million)
  • FIG. 34 U.K. hyaluronic acid-based dermal fillers market, 2018 - 2030 (USD Million)
  • FIG. 35 Germany hyaluronic acid-based dermal fillers market, 2018 - 2030 (USD Million)
  • FIG. 36 France hyaluronic acid-based dermal fillers market, 2018 - 2030 (USD Million)
  • FIG. 37 Italy hyaluronic acid-based dermal fillers market, 2018 - 2030 (USD Million)
  • FIG. 38 Spain hyaluronic acid-based dermal fillers market, 2018 - 2030 (USD Million)
  • FIG. 39 Sweden hyaluronic acid-based dermal fillers market, 2018 - 2030 (USD Million)
  • FIG. 40 Norway hyaluronic acid-based dermal fillers market, 2018 - 2030 (USD Million)
  • FIG. 41 Denmark hyaluronic acid-based dermal fillers market, 2018 - 2030 (USD Million)
  • FIG. 42 Rest of Europe hyaluronic acid-based dermal fillers market, 2018 - 2030 (USD Million)
  • FIG. 43 Asia Pacific hyaluronic acid-based dermal fillers market, 2018 - 2030 (USD Million)
  • FIG. 44 Japan hyaluronic acid-based dermal fillers market, 2018 - 2030 (USD Million)
  • FIG. 45 China hyaluronic acid-based dermal fillers market, 2018 - 2030 (USD Million)
  • FIG. 46 India hyaluronic acid-based dermal fillers market, 2018 - 2030 (USD Million)
  • FIG. 47 Australia hyaluronic acid-based dermal fillers market, 2018 - 2030 (USD Million)
  • FIG. 48 Thailand hyaluronic acid-based dermal fillers market, 2018 - 2030 (USD Million)
  • FIG. 49 South Korea hyaluronic acid-based dermal fillers market, 2018 - 2030 (USD Million)
  • FIG. 50 Rest of Asia Pacific hyaluronic acid-based dermal fillers market, 2018 - 2030 (USD Million)
  • FIG. 51 Latin America hyaluronic acid-based dermal fillers market, 2018 - 2030 (USD Million)
  • FIG. 52 Brazil hyaluronic acid-based dermal fillers market, 2018 - 2030 (USD Million)
  • FIG. 53 Mexico hyaluronic acid-based dermal fillers market, 2018 - 2030 (USD Million)
  • FIG. 54 Argentina hyaluronic acid-based dermal fillers market, 2018 - 2030 (USD Million)
  • FIG. 55 Rest of LATAM hyaluronic acid-based dermal fillers market, 2018 - 2030 (USD Million)
  • FIG. 56 MEA hyaluronic acid-based dermal fillers market, 2018 - 2030 (USD Million)
  • FIG. 57 South Africa hyaluronic acid-based dermal fillers market, 2018 - 2030 (USD Million)
  • FIG. 58 Saudi Arabia hyaluronic acid-based dermal fillers market, 2018 - 2030 (USD Million)
  • FIG. 59 UAE hyaluronic acid-based dermal fillers market, 2018 - 2030 (USD Million)
  • FIG. 60 Kuwait hyaluronic acid-based dermal fillers market, 2018 - 2030 (USD Million)
  • FIG. 61 Rest of MEA hyaluronic acid-based dermal fillers market, 2018 - 2030 (USD Million)
  • FIG. 62 Strategy framework
  • FIG. 63 Market position analysis
  • FIG. 64 KoL commentary
目次
Product Code: GVR-2-68038-999-9

Hyaluronic Acid-based Dermal Fillers Market Growth & Trends:

The global hyaluronic acid-based dermal fillers market size is estimated to reach USD 8.59 billion by 2030, based on a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.9% from 2023 to 2030. Increasing demand for minimally invasive procedures, growing geriatric population, increasing awareness & concern for younger skin and advancement in technology are some of the key factors driving the market.

The global geriatric population is on the rise. Estimates published by the WHO suggest that the global population of the age group 65 years and above is anticipated to rise from 7% in 2000 to 16% in 2050. An associated consequence of this increase in the geriatric population is increase in incidence of obesity, skin aging, and osteoarthritis. Along with growing preference for minimally invasive surgeries, global increase in the target population is expected to significantly propel demand for hyaluronic acid products throughout the forecast period.

However, the higher cost of HA based fillers market is restraining the market opportunities. The HA-based dermal fillers are available in syringes of 1ml costing USD 600-1000 per syringe. Most of the times a dosage of minimum 2 syringes is required, taking the cost of treatment to USD 1600-2000 which is quite high. The high cost of products makes it difficult for the population of low- medium-income countries.

Hyaluronic Acid-based Dermal Fillers Market Report Highlights:

  • Based on the products, the single-phase products held the highest market share in 2022 owing to desired and beneficial effects produced by single-phase products which leads to higher preference among consumers.
  • Based on application, the wrinkle correction segment dominated the market in 2022. This can be attributed to the increasing spending on cosmetic procedures and the advent of technology for wrinkle correction suing HA-based fillers.
  • Based on region, North America dominated the market in 2022. This can be attributed to favorable government policies, a rise in the number of plastic surgery procedures and growing ageing population in the region. For instance, as per the Statistics Canada's population statistics published in September 2021, the total population above 60 years of age in Canada is 96,88,677.
  • The Asia pacific market is expected to have fastest growth during the forecast period owing to the rapid economic growth in nation like Japan, China & South Korea and improvement in healthcare infrastructure in the region.
  • a* Some of the key players of hyaluronic acid-based dermal fillers market are-

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Product
    • 1.1.2 Application
    • 1.1.3 Regional Scope
    • 1.1.4 Estimates and Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
    • 1.6.2 Volume Price Analysis
  • 1.7 List of Secondary Sources
  • 1.8 List of Abbreviations
  • 1.9 Objectives
    • 1.9.1 Objective 1
    • 1.9.2 Objective 2
    • 1.9.3 Objective 3

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
    • 2.2.1 Product
    • 2.2.2 Application
    • 2.2.3 Region
  • 2.3 Competitive Insights

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent market outlook
  • 3.2 Market Segmentation
  • 3.3 Penetration & Growth Prospect Mapping
  • 3.4 Clinical Trials
  • 3.5 User Perspective Analysis
    • 3.5.1 Consumer Behavior Analysis
    • 3.5.2 Market Influencer Analysis
  • 3.6 Market Dynamics
    • 3.6.1 Market Driver Analysis
      • 3.6.1.1 Increasing Geriatric Population
      • 3.6.1.2 Growing demand for anti-aging solutions and minimally invasive aesthetic treatment
      • 3.6.1.3 Growing applications in regenerative medicine and tissue engineering
    • 3.6.2 Market Restraint Analysis
      • 3.6.2.1 High cost and side effects associated with hyaluronic acid cycles
      • 3.6.2.2 Stringent regulations
  • 3.7 Business Environment Analysis Tools
    • 3.7.1 Porter's five forces analysis
      • 3.7.1.1 Bargaining power of buyers: Low
      • 3.7.1.2 Bargaining power of suppliers: Moderate
      • 3.7.1.3 Competitive rivalry: High
      • 3.7.1.4 Threat of new entrants: Moderate
      • 3.7.1.5 Threat of substitutes: Low
    • 3.7.2 SWOT Analysis, by PESTEL
      • 3.7.2.1 Political & legal
      • 3.7.2.2 Economic
      • 3.7.2.3 Technological
    • 3.7.3 Clinical Trials
    • 3.7.4 Major Deals & Strategic Alliances Analysis
      • 3.7.4.1 Joint ventures
      • 3.7.4.2 Mergers & acquisitions
    • 3.7.5 Qualitative Analysis: Impact of COVID-19 on Hyaluronic Acid-based Dermal Fillers Market Market

Chapter 4 Hyaluronic Acid-based Dermal Fillers Market Market: Product Analysis

  • 4.1 Hyaluronic Acid-based Dermal Fillers Market by Product Market Share Analysis, 2022 & 2030
  • 4.2 Segment Dashboard
  • 4.3 Global Hyaluronic Acid-based Dermal Fillers Market Market, by Product, 2018 - 2030
  • 4.4 Market Size and Forecasts and Trend Analysis, 2018 - 2030 for the Product
    • 4.4.1 Single Phase Products
      • 4.4.1.1 Single Phase Products Market-2030 (USD Million)
    • 4.4.2 Duplex Products
      • 4.4.2.1 Duplex Products based market, 2018 - 2030 (USD Million)

Chapter 5Hyaluronic Acid-based Dermal Fillers Market Market: Application Analysis

  • 5.1 Hyaluronic Acid-based Dermal Fillers Market Application Market Share Analysis, 2022 and 2030
  • 5.2 Segment Dashboard
  • 5.3 Market Size and Forecasts and Trend Analysis, 2018 - 2030 for the Following Application
    • 5.3.1 Wirnkle Correction
      • 5.3.1.1 Wrinkle correction market, 2018 - 2030 (USD Million)
    • 5.3.2 Lip Augmentation
      • 5.3.2.1 Lip Augmentation Market, 2018 - 2030 (USD Million)
    • 5.3.3 Rhinoplasty
      • 5.3.3.1 Rhinoplasty Market, 2018 - 2030 (USD Million)
  • 5.4. Rhinoplasty
    • 5.4.1 Rhinoplasty Market, 2018 - 2030 (USD Million)

Chapter 6 Regional Outlook

  • 6.1 Regional market share analysis, 2022 & 2030
  • 6.2 Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
  • 6.3 Market Size, & Forecasts and Trend Analysis, 2022 to 2030
    • 6.3.1 North America
      • 6.3.1.1 North America Hyaluronic Acid-based Dermal Fillers market, By Product 2018 - 2030 (USD Million
      • 6.3.1.2 North America Hyaluronic Acid-based Dermal Fillers market, By Application 2018 - 2030 (USD Million
      • 6.3.1.2 U.S.
      • 6.3.1.2.1 U.S. Hyaluronic Acid-based Dermal Fillers Market By Product, 2018 - 2030 (USD Million)
      • 6.3.1.2.2 U.S. Hyaluronic Acid-based Dermal Fillers Market By Application , 2018 - 2030 (USD Million
      • 6.3.1.3 Canada
      • 6.3.1.3.1 Canada Hyaluronic Acid-based Dermal Fillers Market By Product, 2018 - 2030 (USD Million)
      • 6.3.1.3.2 Canada Hyaluronic Acid-based Dermal Fillers Market By Application, 2018 - 2030 (USD Million)
    • 6.3.2 Europe
      • 6.3.2.1 Europe Hyaluronic Acid-based Dermal Fillers Market By Product, 2018 - 2030 (USD Million)
      • 6.3.2.2 Europe Hyaluronic Acid-based Dermal Fillers Market By Application, 2018 - 2030 (USD Million)
      • 6.3.2.3 U.K.
      • 6.3.2.3.1 U.k. Hyaluronic Acid-based Dermal Fillers Market by Product, 2018 - 2030 (USD Million)
      • 6.3.2.3.2 U.k. Hyaluronic Acid-based Dermal Fillers Market by Application, 2018 - 2030 (USD Million)
      • 6.3.2.4 Germany
      • 6.3.2.4.1 Germany Hyaluronic Acid-based Dermal Fillers by Product, 2018 - 2030 (USD Million)
      • 6.3.2.4.2 Germany Hyaluronic Acid-based Dermal Fillers Market by Application, 2018 - 2030 (USD Million)
      • 6.3.2.5 France
      • 6.3.2.5.1 France Hyaluronic Acid-based Dermal Fillers Market by Product, 2018 - 2030 (USD Million)
      • 6.3.2.5.2 France Hyaluronic Acid-based Dermal Fillers Market by Application, 2018 - 2030 (USD Million)
      • 6.3.2.6 Italy
      • 6.3.2.6.1 Italy Hyaluronic Acid-based Dermal Fillers Market By Product, 2018 - 2030 (USD Million)
      • 6.3.2.6.2 Italy Hyaluronic Acid-based Dermal Fillers Market By Application , 2018 - 2030 (USD Million)
      • 6.3.2.7 Spain
      • 6.3.2.7.1 Spain Hyaluronic Acid-based Dermal Fillers Market by Product, 2018 - 2030 (USD Million)
      • 6.3.2.7.2 Spain Hyaluronic Acid-based Dermal Fillers Market by Application, 2018 - 2030 (USD Million)
      • 6.3.2.8 Sweden
      • 6.3.2.8.1 Sweden Hyaluronic Acid-based Dermal Fillers Market by Product, 2018 - 2030 (USD Million)
      • 6.3.2.8.2 Sweden Hyaluronic Acid-based Dermal Fillers Market by Application, 2018 - 2030 (USD Million)
      • 6.3.2.9 Norway
      • 6.3.2.9.1 Norway Hyaluronic Acid-based Dermal Fillers Market by Product , 2018 - 2030 (USD Million)
      • 6.3.2.9.2 Norway Hyaluronic Acid-based Dermal Fillers Market by Application , 2018 - 2030 (USD Million)
      • 6.3.2.10 Denmark
      • 6.3.2.10.1 Denmark Hyaluronic Acid-based Dermal Fillers Market by Product, 2018 - 2030 (USD Million)
      • 6.3.2.10.2 Denmark Hyaluronic Acid-based Dermal Fillers Market by Application, 2018 - 2030 (USD Million)
      • 6.3.2.11 Rest of Europe
      • 6.3.2.11.1 Rest of Europe Hyaluronic Acid-based Dermal Fillers Market by Product, 2018 - 2030 (USD Million)
      • 6.3.2.11.2 Rest of Europe Hyaluronic Acid-based Dermal Fillers Market by Application, 2018 - 2030 (USD Million)
    • 6.3.3 Asia Pacific
      • 6.3.3.1 Asia Pacific Hyaluronic Acid-based Dermal Fillers Market by Product, 2018 - 2030 (USD Million)
      • 6.3.3.2 Asia Pacific Hyaluronic Acid-based Dermal Fillers Market by Application, 2018 - 2030 (USD Million)
      • 6.3.3.3 Japan
      • 6.3.3.3.1 Japan Hyaluronic Acid-based Dermal Fillers Market by Product, 2018 - 2030 (USD Million)
      • 6.3.3.3.2 Japan Hyaluronic Acid-based Dermal Fillers Market by Application, 2018 - 2030 (USD Million)
      • 6.3.3.4 China
      • 6.3.3.4.1 China Hyaluronic Acid-based Dermal Fillers Market by Product, 2018 - 2030 (USD Million)
      • 6.3.3.4.2 China Hyaluronic Acid-based Dermal Fillers Market by Application, 2018 - 2030 (USD Million)
      • 6.3.3.5 India
      • 6.3.3.5.1 India Hyaluronic Acid-based Dermal Fillers Market by Product, 2018 - 2030 (USD Million)
      • 6.3.3.5.2 India Hyaluronic Acid-based Dermal Fillers Market by Application, 2018 - 2030 (USD Million)
      • 6.3.3.6 Australia
      • 6.3.3.6.1 Australia Hyaluronic Acid-based Dermal Fillers Market by Product, 2018 - 2030 (USD Million)
      • 6.3.3.6.2 Australia Hyaluronic Acid-based Dermal Fillers Market by Application, 2018 - 2030 (USD Million)
      • 6.3.3.7 Thailand
      • 6.3.3.7.1 Thailand Hyaluronic Acid-based Dermal Fillers Market by Product, 2018 - 2030 (USD Million)
      • 6.3.3.7.2 Thailand Hyaluronic Acid-based Dermal Fillers Market by Application, 2018 - 2030 (USD Million)
      • 6.3.3.8 South Korea
      • 6.3.3.8.1 South Korea Hyaluronic Acid-based Dermal Fillers Market by Product, 2018 - 2030 (USD Million)
      • 6.3.3.8.2 South Korea hyaluonic Acid Based Fillers Market by Application, 2018 - 2030 (USD Million)
      • 6.3.3.9 Rest of Asia Pacific
      • 6.3.3.9.1 Rest of Asia Pacific Hyaluronic Acid-based Dermal Fillers Market by Product, 2018 - 2030 (USD Million)
      • 6.3.3.9.2 Rest of Asia Pacific Hyaluonic Acid Based Fillers Market by Application, 2018 - 2030 (USD Million
    • 6.3.4 Latin America
      • 6.3.4.1 Latin America Hyaluronic Acid-based Dermal Fillers Market by Product , 2018 - 2030 (USD Million)
      • 6.3.4.2 Latin America Hyaluronic Acid-based Dermal Fillers Market by Application , 2018 - 2030 (USD Million)
      • 6.3.4.3 Brazil
      • 6.3.4.3.1 Brazil Hyaluronic Acid-based Dermal Fillers Market by Product, 2018 - 2030 (USD Million)
      • 6.3.4.3.2 Brazil Hyaluronic Acid-based Dermal Fillers Market by Application, 2018 - 2030 (USD Million)
      • 6.3.4.4 Mexico
      • 6.3.4.4.1 Mexico Hyaluronic Acid-based Dermal Fillers Market by Product , 2018 - 2030 (USD Million)
      • 6.3.4.4.2 Mexico Hyaluronic Acid-based Dermal Fillers Market by Application, 2018 - 2030 (USD Million)
      • 6.3.4.5 Argentina
      • 6.3.4.5.1 Argentina Hyaluronic Acid-based Dermal Fillers Market by Product, 2018 - 2030 (USD Million)
      • 6.3.4.5.2 Argentina Hyaluronic Acid-based Dermal Fillers Market by Application, 2018 - 2030 (USD Million)
      • 6.3.4.6 Rest of LATAM
      • 6.3.4.6.1 Rest of LATAM Hyaluronic Acid-based Dermal Fillers Market by Product, 2018 - 2030 (USD Million)
      • 6.3.4.6.2 Best of LATAM Hyaluronic Acid-based Dermal Fillers Market by Application, 2018 - 2030 (USD Million)
    • 6.3.5 Middle East & Africa
      • 6.3.5.1 MEA Hyaluronic Acid-based Dermal Fillers Market by Product, 2018 - 2030 (USD Million)
      • 6.3.5.2 MEA Hyaluronic Acid-based Dermal Fillers Market by Application, 2018 - 2030 (USD Million)
      • 6.3.5.3 South Africa
      • 6.3.5.3.1 South Africa Hyaluronic Acid-based Dermal Fillers Market by Product, 2018 - 2030 (USD Million)
      • 6.3.5.3.2 South Africa Hyaluronic Acid-based Dermal Fillers Market by Application, 2018 - 2030 (USD Million)
      • 6.3.5.4 Saudi Arabia
      • 6.3.5.4.1 Saudi Arabia Hyaluronic Acid-based Dermal Fillers Market by Product, 2018 - 2030 (USD Million)
      • 6.3.5.4.3 Saudi Arabia Hyaluronic Acid-based Dermal Fillers Market by Application, 2018 - 2030 (USD Million)
      • 6.3.5.5 UAE
      • 6.3.5.5.1 UAE Hyaluronic Acid-based Dermal Fillers Market by Product, 2018 - 2030 (USD Million)
      • 6.3.5.5.2 UAE Hyaluronic Acid-based Dermal Fillers Market by Application, 2018 - 2030 (USD Million)
      • 6.3.5.6 Kuwait
      • 6.3.5.6.1 Kuwait Hyaluronic Acid-based Dermal Fillers Market by Product, 2018 - 2030 (USD Million)
      • 6.3.5.6.2 Kuwait Hyaluronic Acid-based Dermal Fillers Market by Application, 2018 - 2030 (USD Million)
      • 6.3.5.7 Rest of MEA
      • 6.3.5.7.1 Rest of MEA Hyaluronic Acid-based Dermal Fillers Market by Product, 2018 - 2030 (USD Million)
      • 6.3.5.7.2 Rest of MEA Hyaluronic Acid-based Dermal Fillers Market by Application, 2018 - 2030 (USD Million)

Chapter 7 Competitive Analysis

  • 7.1 Strategic Framework/ Competition Categorization (Key innovators, Market leaders, emerging players
  • 7.2 Vendor Landscape
    • 7.2.1 Strategy Mapping
    • 7.2.2 Launch of New Products
    • 7.2.3 Merger and Acquisition
    • 7.2.4 Product Approvals
    • 7.2.5 Partnerships
    • 7.2.6 Marketing & Promotions
  • 7.3 Company Market Position Analysis
  • 7.4 Company Profiles
    • 7.4.1 Allergan
      • 7.4.1.1 Company overview
      • 7.4.1.2 Financial performance
      • 7.4.1.3 Product benchmarking
      • 7.4.1.4 Strategic initiatives
      • 7.4.1.5 SWOT analysis
    • 7.4.2 Galderma Laboratories L.P.
      • 7.4.2.1 Company overview
      • 7.4.2.2 Financial performance
      • 7.4.2.3 Product benchmarking
      • 7.4.2.4 Strategic initiatives
      • 7.4.2.5 SWOT analysis
    • 7.4.3 Merz Pharmaceuticals
      • 7.4.3.1 Company overview
      • 7.4.3.2 Financial performance
      • 7.4.3.3 Product benchmarking
      • 7.4.3.4 Strategic initiatives
      • 7.4.3.5 SWOT analysis
    • 7.4.4 Genzyme Corporation
      • 7.4.4.1 Company overview
      • 7.4.4.2 Financial performance
      • 7.4.4.3 Product benchmarking
      • 7.4.4.4 Strategic initiatives
      • 7.4.4.5 SWOT analysis
    • 7.4.5 Anika Therapeutics Inc
      • 7.4.5.1 Company overview
      • 7.4.5.2 Financial performance
      • 7.4.5.3 Product benchmarking
      • 7.4.5.4 Strategic initiatives
      • 7.4.5.5 SWOT analysis
    • 7.4.6 LG Life Sciences
      • 7.4.6.1 Company overview
      • 7.4.6.2 Financial performance
      • 7.4.6.3 Product benchmarking
      • 7.4.6.4 Strategic initiatives
      • 7.4.6.5 SWOT analysis
    • 7.4.7 Bio plus Co
      • 7.4.7.1 Company overview
      • 7.4.7.2 Financial performance
      • 7.4.7.3 Product benchmarking
      • 7.4.7.4 Strategic initiatives
      • 7.4.7.5 SWOT analysis
    • 7.4.8 Sculpt Luxury Dermal Fillers Ltd
      • 7.4.8.1 Company overview
      • 7.4.8.2 Financial performance
      • 7.4.8.3 Product benchmarking
      • 7.4.8.4 Strategic initiatives
      • 7.4.8.5 SWOT analysis
    • 7.4.9 Bioxis Pharmaceutical
      • 7.4.9.1 Company overview
      • 7.4.9.2 Financial performance
      • 7.4.9.3 Product benchmarking
      • 7.4.9.4 Strategic initiatives
    • 7.4.10 Sinclair Pharma
      • 7.4.10.1 Company overview
      • 7.4.10.2 Financial Performance
      • 7.4.10.3 Product benchmarking
      • 7.4.10.4 Strategic initiatives
    • 7.4.11 Laboratories Vivacy
      • 7.4.11.1 Company overview
      • 7.4.11.2 Financial performance
      • 7.4.11.3 Services benchmarking
      • 7.4.11.4 Strategic initiatives
    • 7.4.12 Bohus Biotech AB
      • 7.4.12.1 Company overview
      • 7.4.12.2 Financial performance
      • 7.4.12.3 Product benchmarking
      • 7.4.12.4 Strategic initiatives

Chapter 8 Recommendations

  • 8.1 Key Insights